The biodefense from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Biodefense Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The biodefense market size has grown strongly in recent years. It will grow from $17.01 billion in 2023 to $18.55 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to increased government investment in biodefense programs and initiatives, strengthening of regulatory frameworks to fast-track the approval of biodefense products and technologies, enhanced collaboration between government agencies, private sector companies, and academic institutions, rising geopolitical tensions and concerns over bioterrorism.
The biodefense market size is expected to see strong growth in the next few years. It will grow to $26.38 billion in 2028 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to the continued emergence of new infectious diseases, further breakthroughs in biotechnology, strengthening of international collaboration and funding mechanisms to support global biodefense efforts building and upgrading biodefense infrastructure, increasing public awareness and education on biodefense, continued evolution of policies and regulatory frameworks to support innovative biodefense technologies, growing investment from the private sector in biodefense research and development. Major trends in the forecast period include leveraging AI and machine learning for predictive modeling, threat detection, and the development of new biodefense tools, integration of telehealth and remote monitoring technologies for early detection and management of biological threats, focus on the development of next-generation vaccines and therapeutics, AI-driven drug discovery and development processes, improved genomic surveillance and data analytics.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/biodefense-global-market-report
Scope Of Biodefense Market
The Business Research Company’s reports encompass a wide range of information, including:
- Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
- Drivers: Examination of the key factors propelling market growth.
- Trends: Identification of emerging trends and patterns shaping the market landscape.
- Key Segments: Breakdown of the market into its primary segments and their respective performance.
- Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
- Macro Economic Factors: Assessment of broader economic elements impacting the market.
Biodefense Market Overview
Market Drivers –
The recurring threat of emerging infectious diseases is expected to propel the growth of the biodefense market going forward. Infectious diseases refer to illnesses caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi that can spread directly or indirectly from one person to another. The reoccurrence of the threat of emerging infectious diseases highlights the growing challenges posed by pathogens, rapid response, global coordination, and preparedness in biodefense. Biodefense plays a crucial role in infectious disease management by enhancing preparedness, early detection, and rapid response to biological threats, thereby minimizing the impact of outbreaks on public health. For instance, in November 2023, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, it is estimated that globally, there will be around 10.6 million cases of tuberculosis (TB) in 2022, impacting approximately 5.8 million men, 3.5 million women, and 1.3 million children. Therefore, the reoccurring threat of infectious diseases is driving the growth of the biodefense market.
Market Trends –
Major companies operating in the biodefense market are focused on developing innovative solutions, such as nasal COVID-19 vaccines, to enhance global preparedness against biological threats. Nasal vaccines enhance biodefense by offering easier administration, potential for mucosal immunity, reducing reliance on needles, enhancing accessibility, and potentially improving immune response. For instance, in January 2023, Bharat Biotech International Limited, an India-based biotechnology company, launched the iNCOVACC Nasal COVID-19 vaccine, utilizing a recombinant replication-deficient adenovirus vector and featuring a pre-fusion stabilized spike protein. After undergoing successful phase I, II, and III clinical trials, this vaccine is designed for intranasal delivery via nasal drops. It is administered as a nasal drop, with a total of 8 drops (0.5 mL per dose), 4 drops into each nostril, as a 2-dose series given 4 weeks apart.
The biodefense market covered in this report is segmented –
1) By Type: Anthrax, Smallpox, Botulism, Radiation Or Nuclear, Other Types
2) By Biothreat Detection Device: Samplers, Detectors Or Triggering Devices, Identifiers, Assays, Other Biothreat Detection Devices
3) By Application: Hospitals And Clinics, Ambulatory Care Centres, Other Applications
Get an inside scoop of the biodefense market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15993&type=smp
Regional Insights –
North America was the largest region in the biodefense market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biodefense market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the biodefense market are Pfizer Inc., Johnson & Johnson, Merck & Co., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GSK plc, Gilead Sciences Inc, Biogen Inc, Novavax Inc, Ichor Medical Systems, Emergent BioSolutions Inc., Alnylam Pharmaceuticals Inc., Dynavax Technologies, Bavarian Nordic, Siga Technologies Inc., Elusys Therapeutics Inc., Ology Bioservices, Altimmune Inc., Hytest Limited, XOMA Corporation, Cleveland BioLabs Inc., Inovio Pharmaceuticals Inc, Dynport Vaccine Company, ViralClear Pharmaceuticals
Table of Contents
1. Executive Summary
2. Biodefense Market Characteristics
3. Biodefense Market Trends And Strategies
4. Biodefense Market – Macro Economic Scenario
5. Global Biodefense Market Size and Growth
……………………
32. Global Biodefense Market Competitive Benchmarking
33. Global Biodefense Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Biodefense Market
35. Biodefense Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
